SLC27A2 and neoplasm: Additionally, the inhibition of FATP2 expression in MDSCs using adipocetoma drugs can diminish lipid accumulation, reduce ROS, and block the immunosuppressive activity of MDSCs, thereby inhibiting tumor growth (Adeshakin et al., 2021).